Chandni Hindocha, PhD is associate director, cannabinoid science at Jazz Pharmaceuticals. She received her PhD from University College London (UCL) in the neuropsychopharmacology of cannabinoids and their implications in neuropsychiatric disorder and conducted post-doctoral research at UCL and Yale University on the genetics of the endocannabinoid system in addiction and psychosis. She has a background in clinical trials on cannabinoids and the psychopharmacology of addictive disorders. She has been awarded several prestigious awards from academic societies including the British Association of Psychopharmacology and the International College of Neuropsychopharmacology. Dr Hindocha has published over 50 papers on cannabinoids in high impact neuroscientific journals.